Health & Biotech
Stories by Tim Boreham
Health & Biotech
Health Kick Podcast: Cannpal has first mover advantage in the $67bn “hidden gem” animal health market
Health & Biotech
Dr Boreham’s Crucible: Why Prescient now has ‘substance and sizzle’
Health & Biotech
Health Kick Podcast: Chemo’s diminishing role, the ‘personalised’ approach to cancer treatment and PTX’s CAR-T innovations
Health & Biotech
Dr Boreham’s Crucible: Regeneus is now riding the stem cell rollercoaster upwards
Health & Biotech
Health Kick: Zelira’s cannabis-derived insomnia treatment has investors dreaming
Health & Biotech
Dr Boreham’s Crucible: Dimerix not putting all its eggs in one basket
Health & Biotech
Health Kick Podcast: Botanix is using synthetic cannabinoids to treat acne and other skin conditions
Health & Biotech
Dr Boreham’s Crucible: Hydrix who?
Health & Biotech
Health Kick: Pancreatic cancer treater OncoSil continues impressive bounce-back
Health & Biotech
Dr Boreham’s Crucible: Mesoblast within months of 3 major trial results, key regulatory decision
Health & Biotech